Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration

Table 2

Relationship between histopathologic evaluation and KRAS point mutation in specimens of pancreatic cancer (62 cases) obtained by EUS-FXA; citation from [7].

	Histology	KRAS point mutation positive
Insufficient material	7	3 (43%)
No malignancy	11	7 (64%)
Atypical	5	4 (80%)
Suspicion of malignancy	15	12 (80%)
Malignancy material	24	20 (83%)
Total	62	46